de-extinction
3 stories filed under de-extinction on Beyond Market Intelligence. The newest of them: “AI platform accelerates de-extinction work as new fund backs its adopters”, “Explore how AI is reshaping the future of species revival”, and “Colossal Biosciences eyes new funding to double its de-extinction valuation.”. Colossal's new AI platform aims to speed up de-extinction work, and Peter Diamandis has launched a fund to back startups that adopt it. Not long ago, bringing an extinct species back to life was science fiction. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every de-extinction story on Beyond Market Intelligence, newest first.
AI platform accelerates de-extinction work as new fund backs its adopters
Colossal's new AI platform aims to speed up de-extinction work, and Peter Diamandis has launched a fund to back startups that adopt it. This pairing of technology and capital could turn ambitious rewilding projects into practical workflows. We see a pattern here: just as Apple TV 4K's Siri AI transforms your viewing experience starting November 13, Colossal is betting AI can reshape what's possible in biology. Explore our coverage of that story for another look at AI-driven transformation.
Explore how AI is reshaping the future of species revival
Not long ago, bringing an extinct species back to life was science fiction. Today, it's the mission of a billion-dollar startup, and it's happening now. At TechCrunch Disrupt 2026, we'll hear from one of tech's most unconventional founders on how AI can engineer nature's comeback. It's a bold, practical challenge to how we think about restoration. If you're curious about the mechanics behind such ambition, our related piece on verifying AI's understanding offers a grounded starting point. Secure your Disrupt pass today.
Colossal Biosciences eyes new funding to double its de-extinction valuation.
Colossal Biosciences is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion, a move that would double or triple its previous worth. That kind of ambition signals confidence in a mission that goes far beyond the lab. It's a bold bet on the future of genetic restoration, and one worth watching closely. For more on how AI-native infrastructure is reshaping similar ventures, check out our piece on Nscale's recent funding.